These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28384330)

  • 1. Correction: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.
    Wolkewitz M; Schumacher M
    PLoS One; 2017; 12(4):e0175660. PubMed ID: 28384330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.
    Wolkewitz M; Schumacher M
    PLoS One; 2016; 11(9):e0160430. PubMed ID: 27583403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Discrimination of influenza infection (A/2009 H1N1) from prior exposure by antibody protein microarray analysis.
    The
    PLoS One; 2015; 10(2):e0118047. PubMed ID: 25658917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children.
    Verschoor CP; Singh P; Russell ML; Bowdish DM; Brewer A; Cyr L; Ward BJ; Loeb M
    PLoS One; 2016; 11(9):e0163830. PubMed ID: 27658259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early therapy with neuraminidase inhibitors for influenza A (H1N1) pdm 2009 infection.
    Yamamoto T; Ihashi M; Mizoguchi Y; Kaneno H; Yamamoto K; Inoue Y; Kase T; Okabe N; Shimotsuji T
    Pediatr Int; 2013 Dec; 55(6):714-21. PubMed ID: 23745743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).
    Ohnishi K; Nakamura-Uchiyama F
    J Infect Chemother; 2010 Feb; 16(1):62-3. PubMed ID: 20072797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.
    Sugaya N; Shinjoh M; Mitamura K; Takahashi T
    J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies.
    Noto H; Goto A; Tsujimoto T; Noda M
    PLoS One; 2019; 14(2):e0212203. PubMed ID: 30730988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival biases lead to flawed conclusions in observational treatment studies of influenza patients.
    Wolkewitz M; Schumacher M
    J Clin Epidemiol; 2017 Apr; 84():121-129. PubMed ID: 28188897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study.
    Li H; Li L; Gu J; Li Y; Chen X; Yang D
    PLoS One; 2017; 12(4):e0176806. PubMed ID: 28445552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?
    Caini S; Andrade W; Badur S; Balmaseda A; Barakat A; Bella A; Bimohuen A; Brammer L; Bresee J; Bruno A; Castillo L; Ciblak MA; Clara AW; Cohen C; Daouda C; de Lozano C; De Mora D; Dorji K; Emukule GO; Fasce RA; Feng L; Ferreira de Almeida WA; Guiomar R; Heraud JM; Holubka O; Huang QS; Kadjo HA; Kiyanbekova L; Kosasih H; Kusznierz G; Lee V; Lara J; Li M; Lopez L; Mai HP; Pessanha HC; Matute ML; Mironenko A; Moreno B; Mott JA; Njouom R; Nurhayati ; Ospanova A; Owen R; Pebody R; Pennington K; Puzelli S; Quynh Le MT; Razanajatovo NH; Rodrigues A; Rudi JM; Venter M; Vernet MA; Wei AL; Wangchuk S; Yang J; Yu H; Zambon M; Schellevis F; Paget J;
    PLoS One; 2016; 11(5):e0155089. PubMed ID: 27135748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors.
    Perez-Sautu U; Pozo F; Cuesta I; Monzon S; Calderon A; Gonzalez M; Molinero M; Lopez-Miragaya I; Rey S; Cañizares A; Rodriguez G; Gonzalez-Velasco C; Lackenby A; Casas I
    Euro Surveill; 2014 Jul; 19(27):14-20. PubMed ID: 25033052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
    Liu H; Yao X; Wang C; Han J
    Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses.
    Jandaghi NZ; Azad TM; Naseri M; Yavarian J; Nategh R
    Arch Virol; 2010 May; 155(5):717-21. PubMed ID: 20306276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Enrichment of minor allele of SNPs and genetic prediction of type 2 diabetes risk in British population.
    Lei X; Huang S
    PLoS One; 2018; 13(1):e0191210. PubMed ID: 29315351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.